Several studies showed that IFITM1 critically regulates epidermal growth factor receptor-mediated signaling in non-small cell lung cancer models and is associated with a poor prognosis of patients with adenocarcinoma (49–51). The gene discussed is IFITM1; the disease is adenocarcinoma.